INmune Bio extends poison pill rights agreement to December 31, 2026

Inmune Bio, Inc.

Amendment No. 5 to Rights Agreement dated Dec 5, 2025 extends expiration to Dec 31, 2026.
Expiration date will auto-extend for successive one-year terms unless Board decides otherwise.
Rights Agreement originally dated Dec 30, 2020 between INmune Bio and VStock Transfer LLC.
No other changes to terms of the shareholder rights plan were disclosed.

item 1.01 item 3.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Inmune Bio, Inc. amended Rights Agreement with VStock Transfer, LLC (effective 2025-12-05).

Action: amendment
Counterparty: VStock Transfer, LLC
Effective: 2025-12-05

Exact text from the filing

On December 5, 2025, INmune Bio Inc. (the “Company”) entered into Amendment No. 5 (the “Amendment”) to the Rights Agreement, dated as of December 30, 2020, between the Company and VStock Transfer, LLC, as Rights Agent, as amended (the “Rights Agreement”).

View on SEC.gov

Browse all material agreements →

Inmune Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-119217

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.